TransCode Therapeutics Incの企業情報（従業員数・代表者名など）
企業情報
| 特色 | TransCode Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative drugs for treating metastatic disease. Co.'s lead therapeutic candidate, TTX-MC138, is an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. |
|---|---|
| 英文社名 | TransCode Therapeutics Inc |
| 本社所在地 | 6 Liberty Square, #2382 Boston, MA 02109 USA |
| 電話番号 | 857 837-3099 |
| 設立年月 | --- |
| 代表者名 | --- |
| 業種名 | 医療関連（Health Care） |
| 市場名 | --- |
| 従業員数 | --- |
| ウェブサイト | www.transcodetherapeutics.com |
